RSS   Newsletter   Contact   Advertise with us
Post Online Media

Intrexon senior vice president Samuel Broder to retire

IntrexonIntrexon Corporation, a biotechnology company, announced the retirement of Samuel Broder, senior vice president and head of Intrexon's health sector.
Dr. Broder has an extensive career in health and previously served as Chairman of the Health Sector and Executive Vice President of Scientific and Public Affairs for Intrexon.

Prior to Intrexon, he was Executive Vice President and Chief Medical Officer at Celera and Senior Vice President of Research and Development at IVAX Corporation. He also served as Director of the National Cancer Institute (NCI) for six years.

During his tenure at NCI, Dr. Broder directed a number of large clinical trials and was instrumental in developing anti-cancer therapeutics as well as several drugs now widely used in the treatment of AIDS.

Dr. Broder has authored or co-authored more than 340 scientific publications, holds multiple patents, and is a member of the Institute of Medicine of the National Academy of Sciences. He received his M.D. from the University of Michigan.




POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.